Triheptanoin - Ultragenyx Pharmaceutical
At a glance
- Drug Originator Baylor Research Institute
- Drug Licenced by Ultragenyx Pharmaceutical
- Drug Class Esters; Small molecules; Triglycerides
- Mechanism of Action Triglyceride replacements
- USA Patent Applicants ULTRAGENYX PHARM INC
- USA Patents 3
- NDAs 1
- International Patents 8
- Patent Applications 452

Disclaimer